Laddar...
Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines
Estrogen receptor modulators and estrogen deprivation have become standards of care for hormone receptor–positive metastatic breast cancer. However, after traditional first-line endocrine monotherapy treatment, the disease typically progresses despite the initial high rate of clinical benefit. Multi...
Sparad:
| I publikationen: | Curr Oncol |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Multimed Inc.
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001771/ https://ncbi.nlm.nih.gov/pubmed/29910656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.4000 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|